Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jessica L. Podcasy & C. Neill Epperson. (2016) Considering sex and gender in Alzheimer disease and other dementias
. Dialogues in Clinical Neuroscience 18:4, pages 437-446.
Read now
Read now
Articles from other publishers (72)
Mélanie Bourque, Marc Morissette & Thérèse Di Paolo. (2024) Neuroactive steroids and Parkinson’s disease: Review of human and animal studies. Neuroscience & Biobehavioral Reviews 156, pages 105479.
Crossref
Crossref
Mieke DuMont, Alyssa Agostinis, Kiran Singh, Evan Swan, Yvonne Buttle & Daniela Tropea. (2023) Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies. Neurobiology of Disease 184, pages 106214.
Crossref
Crossref
Felwah S. Al-Zaid, Michael J. Hurley, David T. Dexter & Glenda E. Gillies. (2023) Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell line. npj Parkinson's Disease 9:1.
Crossref
Crossref
Takayasu Mishima, Shih-Wei Chiu, Hidemoto Saiki, Takuhiro Yamaguchi, Yasushi Shimo, Tetsuya Maeda, Hirohisa Watanabe, Kenichi Kashihara, Masahiro Nomoto, Nobutaka Hattori & Yoshio Tsuboi. (2023) Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST. Journal of the Neurological Sciences 448, pages 120619.
Crossref
Crossref
Léon-Charles Tranchevent, Rashi Halder & Enrico Glaab. (2023) Systems level analysis of sex-dependent gene expression changes in Parkinson’s disease. npj Parkinson's Disease 9:1.
Crossref
Crossref
Amandine Isenbrandt, Katherine Coulombe, Marc Morissette, Mélanie Bourque, Jérôme Lamontagne-Proulx, Thérèse Di Paolo & Denis Soulet. (2023) Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease. Pharmaceuticals 16:2, pages 152.
Crossref
Crossref
Rhonda Voskuhl & Yuichiro Itoh. (2022) The X factor in neurodegeneration. Journal of Experimental Medicine 219:12.
Crossref
Crossref
A. U. Hamadyanova, K. O. Kuznetsov, E. I. Gaifullina, D. A. Kalandin, R. R. Khamidullina, I. F. Khalitova, R. M. Faizov, N. O. Kamaletdinova, B. F. Aslanova, A. G. Nakieva, L. E. Burangulova & G. O. Gaisina. (2022) Androgens and Parkinson’s disease: the role in humans and in experiment. Problems of Endocrinology 68:6, pages 146-156.
Crossref
Crossref
Yangfan Zhao & Sarah A. Gagliano Taliun. (2022) Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study. Frontiers in Neurology 13.
Crossref
Crossref
Stephan Listabarth, Magdalena Groemer, Thomas Waldhoer, Benjamin Vyssoki, Nathalie Pruckner, Sandra Vyssoki, Alexander Glahn, Deirdre Maria König-Castillo & Daniel König. (2022) Cognitive decline and alcohol consumption in the aging population—A longitudinal analysis of the Survey of Health, Ageing and Retirement in Europe. European Psychiatry 65:1.
Crossref
Crossref
Mélanie BourqueDenis SouletThérèse Di Paolo. (2021) Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models. Androgens: Clinical Research and Therapeutics 2:1, pages 294-303.
Crossref
Crossref
Nicole Petersen, Andrea J. Rapkin, Kyoji Okita, Kaitlin R. Kinney, Tomi Mizuno, Mark A. Mandelkern & Edythe D. London. (2021) Striatal dopamine D2-type receptor availability and peripheral 17β-estradiol. Molecular Psychiatry 26:6, pages 2038-2047.
Crossref
Crossref
Bhupesh Vaidya, Kritika Dhamija, Priyanka Guru & Shyam Sunder Sharma. (2021) Parkinson's disease in women: Mechanisms underlying sex differences. European Journal of Pharmacology 895, pages 173862.
Crossref
Crossref
Meagan R. Conner, Doyeon Jang, Brenda J. Anderson & Mary F. Kritzer. (2020) Biological Sex and Sex Hormone Impacts on Deficits in Episodic-Like Memory in a Rat Model of Early, Pre-motor Stages of Parkinson's Disease. Frontiers in Neurology 11.
Crossref
Crossref
Nobutaka Hattori, Hiroki Kitabayashi, Tomoyuki Kanda, Takanobu Nomura, Keizo Toyama & Akihisa Mori. (2020) A Pooled Analysis From Phase 2b and 3 Studies in Japan of Istradefylline in Parkinson's Disease. Movement Disorders 35:8, pages 1481-1487.
Crossref
Crossref
Ye Zhang, Rong Ren, Larry D. Sanford, Linghui Yang, Junying Zhou, Lu Tan, Taomei Li, Jihui Zhang, Yun-Kwok Wing, Jie Shi, Lin Lu & Xiangdong Tang. (2020) Sleep in Parkinson's disease: A systematic review and meta-analysis of polysomnographic findings. Sleep Medicine Reviews 51, pages 101281.
Crossref
Crossref
Nirmal K. Sampathkumar, Juan I. Bravo, Yilin Chen, Prakroothi S. Danthi, Erin K. Donahue, Rochelle W. Lai, Ryan Lu, Lewis T. Randall, Nika Vinson & Bérénice A. Benayoun. (2019) Widespread sex dimorphism in aging and age-related diseases. Human Genetics 139:3, pages 333-356.
Crossref
Crossref
Julia M. Marquis, Samantha E. Lettenberger & Cynthia A. Kelm-Nelson. (2020) Early-onset Parkinsonian behaviors in female Pink1-/- rats. Behavioural Brain Research 377, pages 112175.
Crossref
Crossref
Angus D. Macleod & Carl E. Counsell. (2019) Treatment Responsiveness of Motor Features in Parkinson's Disease: A Matched Case‐Control Analysis. Movement Disorders Clinical Practice 7:1, pages 45-51.
Crossref
Crossref
José M.M. Bispo, João E.C. Melo, Auderlan M. Gois, Pollyana C. Leal, Lívia C.R.F. Lins, Marina F. Souza, Katty A.A.L. Medeiros, Alessandra M. Ribeiro, Regina H. Silva, Murilo Marchioro & José R. Santos. (2019) Sex differences in the progressive model of parkinsonism induced by reserpine in rats. Behavioural Brain Research 363, pages 23-29.
Crossref
Crossref
Mélanie Bourque, Marc Morissette & Thérèse Di Paolo. (2019) Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease. Neuropharmacology 147, pages 37-54.
Crossref
Crossref
Michael T. Hayes. 2019. Neurology and Psychiatry of Women. Neurology and Psychiatry of Women
213
217
.
Michelle E. Fullard, Dylan P. Thibault, Veronica Todaro, Susan Foster, Lori Katz, Robin Morgan, Drew S. Kern, Jason M. Schwalb, Enrique Urrea Mendoza, Nabila Dahodwala, Lisa Shulman & Allison W. Willis. (2018) Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability. Parkinsonism & Related Disorders 48, pages 45-50.
Crossref
Crossref
T. N. Seyfried, H. Choi, A. Chevalier, D. Hogan, Z. Akgoc & J. S. Schneider. (2018) Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease. ASN Neuro 10, pages 175909141878188.
Crossref
Crossref
Peter T. Nelson, Wang-Xia Wang, Sarah A. Janse & Katherine L. Thompson. (2018) MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls. Brain Research 1678, pages 374-383.
Crossref
Crossref
Marc Morissette, Nadhir Litim & Thérèse Di Paolo. 2018. Discovery and Development of Neuroprotective Agents from Natural Products. Discovery and Development of Neuroprotective Agents from Natural Products
9
61
.
Cassandra E. Meyer, Florian Kurth, Stefano Lepore, Josephine L. Gao, Hadley Johnsonbaugh, Mandavi R. Oberoi, Stephen J. Sawiak & Allan MacKenzie-Graham. (2017) In vivo magnetic resonance images reveal neuroanatomical sex differences through the application of voxel-based morphometry in C57BL/6 mice. NeuroImage 163, pages 197-205.
Crossref
Crossref
Julieta Mendes-Oliveira, Filipa Lopes Campos, Rita Alexandra Videira & Graça Baltazar. (2017) GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment. Brain, Behavior, and Immunity 64, pages 296-307.
Crossref
Crossref
Erika Betancourt, Jonathan Wachtel, Michalis Michaelos, Michael Haggerty, Jessica Conforti & Mary F. Kritzer. (2017) The impact of biological sex and sex hormones on cognition in a rat model of early, pre-motor Parkinson’s disease. Neuroscience 345, pages 297-314.
Crossref
Crossref
Santosh K. Yadav, Nagarajan Kathiresan, Suyash Mohan, Georgia Vasileiou, Anup Singh, Deepak Kaura, Elias R. Melhem, Rakesh K. Gupta, Ena Wang, Francesco M. Marincola, Arijitt Borthakur & Mohammad Haris. (2016) Gender-based analysis of cortical thickness and structural connectivity in Parkinson’s disease. Journal of Neurology 263:11, pages 2308-2318.
Crossref
Crossref
Mei Dai, Benjamin Liou, Brittany Swope, Xiaohong Wang, Wujuan Zhang, Venette Inskeep, Gregory A. Grabowski, Ying Sun & Dao Pan. (2016) Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease. PLOS ONE 11:9, pages e0162367.
Crossref
Crossref
Nadhir Litim, Marc Morissette & Thérèse Di Paolo. (2016) Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease. Neuroscience & Biobehavioral Reviews 67, pages 79-88.
Crossref
Crossref
Gretchen N. Neigh & Liana Merrill. 2016. Sex Differences in Physiology. Sex Differences in Physiology
17
44
.
Anne Almey, Teresa A. Milner & Wayne G. Brake. (2015) Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females. Hormones and Behavior 74, pages 125-138.
Crossref
Crossref
Hannah Loke, Vincent Harley & Joohyung Lee. (2015) Biological factors underlying sex differences in neurological disorders. The International Journal of Biochemistry & Cell Biology 65, pages 139-150.
Crossref
Crossref
Valtteri Kaasinen, Juho Joutsa, Tommi Noponen, Jarkko Johansson & Marko Seppänen. (2015) Effects of aging and gender on striatal and extrastriatal [ 123 I]FP-CIT binding in Parkinson's disease. Neurobiology of Aging 36:4, pages 1757-1763.
Crossref
Crossref
D.G. Lichter & S.G. Finnegan. (2020) Influence of Gender on Tourette Syndrome Beyond Adolescence. European Psychiatry 30:2, pages 334-340.
Crossref
Crossref
Roberto Yunes, Sebastián Casas, Eliana Gaglio & Ricardo Cabrera. (2015)
Progesterone Exerts a Neuromodulatory Effect on Turning Behavior of Hemiparkinsonian Male Rats: Expression of 3
α
-Hydroxysteroid Oxidoreductase and Allopregnanolone as Suggestive of
Receptors Involvement
. Parkinson's Disease 2015, pages 1-9.
Crossref
Crossref
Chizoba C. Umeh, Adriana Pérez, Erika F. Augustine, Rohit Dhall, Richard B. Dewey, Zoltan Mari, David K. Simon, Anne-Marie A. Wills, Chadwick W. Christine, Jay S. Schneider & Oksana Suchowersky. (2014) No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial. PLoS ONE 9:12, pages e112287.
Crossref
Crossref
Glenda E. Gillies, Ilse S. Pienaar, Shiv Vohra & Zahi Qamhawi. (2014) Sex differences in Parkinson’s disease. Frontiers in Neuroendocrinology 35:3, pages 370-384.
Crossref
Crossref
Diego Orcioli-Silva, Fabio Augusto Barbieri, Lucas Simieli, Natália Madalena Rinaldi, Rodrigo Vitório & Lilian Teresa Bucken Gobbi. (2014) Effects of a multimodal exercise program on the functional capacity of Parkinson's disease patients considering disease severity and gender. Motriz: Revista de Educação Física 20:1, pages 100-106.
Crossref
Crossref
Kalpit Shah, Charles E. McCormack & Neil A. Bradbury. (2014) Do you know the sex of your cells?. American Journal of Physiology-Cell Physiology 306:1, pages C3-C18.
Crossref
Crossref
Amel M.M. Abdel-Hafez & Heba K. Mohamed. (2013) Sex differences in dopaminergic neurons of substantia nigra pars compacta of adult and aged rats. The Egyptian Journal of Histology 36:4, pages 952-963.
Crossref
Crossref
Lana J. Mawhinney, Davita Mabourakh & Michael C. Lewis. (2012) Gender-Specific Differences in the Central Nervous System’s Response to Anesthesia. Translational Stroke Research 4:4, pages 462-475.
Crossref
Crossref
S. Mandillo, E. Golini, D. Marazziti, C. Di Pietro, R. Matteoni & G. P. Tocchini‐Valentini. (2013)
Mice lacking the Parkinson's related
GPR37
/
PAEL
receptor show non‐motor behavioral phenotypes: age and gender effect
. Genes, Brain and Behavior 12:4, pages 465-477.
Crossref
Crossref
Flavia di Michele, Sabina Luchetti, Giorgio Bernardi, Elena Romeo & Patrizia Longone. (2013) Neurosteroid and neurotransmitter alterations in Parkinson’s disease. Frontiers in Neuroendocrinology 34:2, pages 132-142.
Crossref
Crossref
O. Chillag-Talmor, N. Giladi, S. Linn, T. Gurevich, B. El-Ad, B. Silverman, N. Friedman & C. Peretz. (2012) Estimation of Parkinson’s disease survival in Israeli men and women, using health maintenance organization pharmacy data in a unique approach. Journal of Neurology 260:1, pages 62-70.
Crossref
Crossref
Caroline Davis, Liana Fattore, Allan S. Kaplan, Jacqueline C. Carter, Robert D. Levitan & James L. Kennedy. (2011) The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults. The International Journal of Neuropsychopharmacology 15:02, pages 181-187.
Crossref
Crossref
S. Al Sweidi, M. G. Sánchez, M. Bourque, M. Morissette, D. Dluzen & T. Di Paolo. (2012) Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease. Journal of Neuroendocrinology 24:1, pages 48-61.
Crossref
Crossref
Sara Al-Sweidi, Marc Morissette, Mélanie Bourque & Thérèse Di Paolo. (2011) Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease. Neuropharmacology 61:4, pages 583-591.
Crossref
Crossref
Gun-Marie Hariz, Takeshi Nakajima, Patricia Limousin, Tom Foltynie, Ludvic Zrinzo, Marjan Jahanshahi & Katarina Hamberg. (2011) Gender distribution of patients with Parkinson’s disease treated with subthalamic deep brain stimulation; a review of the 2000–2009 literature. Parkinsonism & Related Disorders 17:3, pages 146-149.
Crossref
Crossref
Eleni Antzoulatos, Michael W. Jakowec, Giselle M. Petzinger & Ruth I. Wood. (2011) MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 Mouse. Parkinson's Disease 2011, pages 1-10.
Crossref
Crossref
L.K. Prashanth, Susan Fox & Wassilios G. Meissner. 2011. Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia. Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia
31
54
.
Glenda E. Gillies & Simon McArthur. (2010) Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines. Pharmacological Reviews 62:2, pages 155-198.
Crossref
Crossref
Luigi Michele Romito, Fiorella Maria Contarino & Alberto Albanese. (2009) Transient gender-related effects in Parkinson’s disease patients with subthalamic stimulation. Journal of Neurology 257:4, pages 603-608.
Crossref
Crossref
Glenda E. Gillies & Simon McArthur. (2010) Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens. Hormones and Behavior 57:1, pages 23-34.
Crossref
Crossref
M. Ragland, C. Hutter, C. Zabetian & K. Edwards. (2009) Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis. American Journal of Epidemiology 170:11, pages 1344-1357.
Crossref
Crossref
Mélanie Bourque, Dean E. Dluzen & Thérèse Di Paolo. (2009) Neuroprotective actions of sex steroids in Parkinson’s disease. Frontiers in Neuroendocrinology 30:2, pages 142-157.
Crossref
Crossref
Quan-Gui Gao, Wen-Fang Chen, Jun-Xia Xie & Man-Sau Wong. (2009) Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. Journal of Neurochemistry 109:5, pages 1338-1347.
Crossref
Crossref
Carlos Penaloza, Brian Estevez, Shari Orlanski, Marianna Sikorska, Roy Walker, Catherine Smith, Brandon Smith, Richard A. Lockshin & Zahra Zakeri. (2009) Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells. The FASEB Journal 23:6, pages 1869-1879.
Crossref
Crossref
Chandani Lewis & Dean E. Dluzen. (2008) Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice. Neuroscience Letters 448:1, pages 130-133.
Crossref
Crossref
Marc Morissette, Sara Al Sweidi, Sophie Callier & Thérèse Di Paolo. (2008) Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Molecular and Cellular Endocrinology 290:1-2, pages 60-69.
Crossref
Crossref
D.E. Dluzen, S. Bhatt & J.L. McDermott. (2008) Differences in reserpine-induced striatal dopamine output and content between female and male mice: Implications for sex differences in vesicular monoamine transporter 2 function. Neuroscience 154:4, pages 1488-1496.
Crossref
Crossref
Jing Ji & Dean E. Dluzen. (2008) Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. Journal of Neural Transmission 115:6, pages 809-817.
Crossref
Crossref
Molly Daymont Price & Lisa M Shulman. (2016) Management of Parkinson's disease in older women. Menopause International 14:1, pages 38-39.
Crossref
Crossref
M. Morissette, M. Le Saux, M. D’Astous, S. Jourdain, S. Al Sweidi, N. Morin, E. Estrada-Camarena, Pablo Mendez, Luis Miguel Garcia-Segura & T. Di Paolo. (2008) Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. The Journal of Steroid Biochemistry and Molecular Biology 108:3-5, pages 327-338.
Crossref
Crossref
Mélanie Bourque, Bin Liu, Dean E. Dluzen & Thérèse Di Paolo. (2007) Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity. Biochemical Pharmacology 74:9, pages 1413-1423.
Crossref
Crossref
J.L. McDermott & D.E. Dluzen. (2007) Aging and sex differences in striatal dopaminergic function. Neuroscience 149:2, pages 401-408.
Crossref
Crossref
S. Karakaya, M. Kipp & C. Beyer. (2007) Oestrogen Regulates the Expression and Function of Dopamine Transporters in Astrocytes of the Nigrostriatal System. Journal of Neuroendocrinology 19:9, pages 682-690.
Crossref
Crossref
Marc Morissette, Sandra Jourdain, Sara Al Sweidi, Frank S. Menniti, Andres D. Ramirez & Thérèse Di Paolo. (2007) Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity. Neuropharmacology 52:7, pages 1509-1520.
Crossref
Crossref
Darrell W. Brann, Krishnan Dhandapani, Chandramohan Wakade, Virendra B. Mahesh & Mohammad M. Khan. (2007) Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications. Steroids 72:5, pages 381-405.
Crossref
Crossref
Shoshana Spring, Jason P. Lerch & R. Mark Henkelman. (2007) Sexual dimorphism revealed in the structure of the mouse brain using three-dimensional magnetic resonance imaging. NeuroImage 35:4, pages 1424-1433.
Crossref
Crossref